For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Anticancer, Inc.

USPTO Granted Patents = 66

CIPO Patents = 1

EPO Patents = 15

Trademarks = 3

Forward Citations = 682

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Yuying Tan (31 out of 31 patents)

Mingxu Xu (16 out of 16 patents)

Lingna Li (15 out of 16 patents)

4. Qinghong Han (10 out of 12 patents)

5. Valeryi Lishko (8 out of 8 patents)

6. Meng Yang (7 out of 8 patents)

7. Shukuan Li (6 out of 6 patents)

8. Robert M Hoffman (5 out of 7 patents)

9. Shigeo Yagi (5 out of 5 patents)

10. Li Tang (5 out of 5 patents)

11. Takashi Chishima (5 out of 5 patents)

12. Ming Zhao (4 out of 4 patents)

13. Zhijian Yang (4 out of 4 patents)

14. Xinghua Sun (4 out of 4 patents)

15. Eugene Baranov (4 out of 8 patents)

Core Competencies:

COVID-19 Treatment

Bacterial Cancer Therapy

Protein PEG Conjugation

Cancer Biomarkers

Tumor Metastasis Models

Gene Therapy

Hair Growth Promotion

Selenium Pro-drugs

Histoculturing Techniques

Immunocompromised Rodent Models

Methioninase Applications

Optical Imaging of Gene Expression

66 patents: Sort by Forward Citations

1. 12023370 - Composition for the treatment of COVID-19 infection, and a method of treatment (2024-07-02),

2. 11871731 - Transplantation method to increase the establishment rate of human tumors in immunodeficient mice (2024-01-16),

3. 11001826 - Orally administered composition to lower serum methionine levels and method of use (2021-05-11),

4. 9539290 - Individualized bacterial treatment of pancreatic cancer (2017-01-10),

5. 9464312 - Schiff-base conjugate of N, N-dibutyl-P-phenylenediamine with pyridoxal 5'-phosphate for improved homocysteine assays using pyridoxal 5′-phosphate-dependent enzymes (2016-10-11),

6. 8822194 - Cancer selective auxotrophs (2014-09-02),

7. 8481318 - Nestin-expressing hair follicle stem cells (2013-07-09),

8. 8465734 - Methods for increasing protein polyethylene glycol (PEG) conjugation (2013-06-18),

9. 8217222 - Methods for identifying markers for early-stage human cancer, cancer progression and recurrence (2012-07-10),

10. 8148600 - Immunocompromised rodents as dual color tumor models (2012-04-03),

11. 7799549 - Methods for increasing protein polyethylene glycol (PEG) conjugation (2010-09-21),

12. 7666675 - Nestin-expressing hair follicle stem cells (2010-02-23),

13. 7625550 - Enhanced resolution of tumor metastasis using a skin flap model (2009-12-01),

14. 7556825 - Method for promoting hair growth (2009-07-07),

15. 7329516 - Methods for increasing protein polyethylene glycol (PEG) conjugation (2008-02-12),

ANTICANCER, INC. is a leading biopharmaceutical company focused on developing innovative cancer treatments. With a strong dedication to improving patient outcomes, our team of experienced scientists and researchers work tirelessly to discover novel therapies that target various forms of cancer. Our goal is to provide patients with effective and personalized treatments that enhance their quality of life. Visit our website to learn more about our groundbreaking research and ongoing clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

66 Patents

#96 in San Diego, CA

#1,256 in California

#5,300 in US

#10,736 in the World

San Diego, CA, United States of America

Anticancer, Inc.

Forward Citations = 682

40 inventors:

Yuying Tan (31 out of 31 patents)

Mingxu Xu (16 out of 16 patents)

Lingna Li (15 out of 16 patents)

4. Qinghong Han (10 out of 12 patents)

5. Valeryi Lishko (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…